• Canada
• Publicationsclose
• NRC Publications Archive close

Under the trend of antibiotic resistance of H. pylori leading to the decrease of eradication rate, the development of a vaccine is the best choice to fight against H. pylori. In this study, we attempted to reduce the amounts of required antigens by using three different parenteral routes of immunization and an adjuvant cGAMP (cyclic guanosine monophosphate-adenosine monophosphate) to enhance the immunogenicity of the vaccine candidate. The immune protection and post-challenge immune responses were assessed and compared in mice immunized with recombinant Helicobacter pylori urease A, urease B, and neutrophil-activating protein adjuvanted with cGAMP. The gastric mucosal colonization by H. pylori was significantly reduced in mice immunized by intranasal and, to a less degree, subcutaneous route, but not by intramuscular route. All immunized mice, regardless of the route of immunization, displayed significant, but comparable, increases in antigen-specific serum IgG and mucosal IgA responses 5 weeks post-challenge. The magnitude of the vaccine-induced protection appeared to be associated with the level of antigen-specific Th1 and particularly Th17 responses, as IL-17 responses were only detected in intranasally immunized mice. Taken together, we explored and confirmed the possibility of using a novel adjuvant (cGAMP) to induce significant protective immunity with 10% of oral vaccine antigen dosage through parenteral immunization, especially intranasal immunization. This may provide an alternative approach to oral immunization for the development of effective H. pylori vaccines.

The National Research Council of Canada (NRC) has developed and patented three high-resolution 3D imaging systems and processing algorithms which have been applied to a wide range of museum and heritage recording applications. The systems have been designed for different imaging applications and, in collaboration with a number of national and international museums and cultural agencies, have been used to scan a wide variety of objects and sites. The objective of this paper is to present a summary of the 3D technology and examples of its heritage applications. Copyright © 2003 John Wiley & Sons, Ltd.

Freezing and thawing properties of cement paste were studied using an alternating current impedance spectroscopy (ACIS) technique coupled with the thermomechanical analysis (TMA). The measurements from the ACIS were analyzed in association with the length change of the cement paste determined by TMA. The micro-scale behavior of cement paste observed by the ACIS technique was well correlated with the residual expansion of cement paste after the freezing and thawing cycle. The efficacy of the ACIS technique for assessing the durability of cement paste to frost action was confirmed.

Infection by Hepatitis C virus (HCV) can lead to liver cirrhosis/hepatocellular carcinoma and remains a major cause of serious disease morbidity and mortality worldwide. However, current treatment regimens remain inaccessible to most patients, particularly in developing countries, and, therefore, the development of a novel vaccine capable of protecting subjects from chronic infection by HCV could greatly reduce the rates of HCV infection, subsequent liver pathogenesis, and in some cases death. Herein, we evaluated two different semi-synthetic archaeosome formulations as an adjuvant to the E1/E2 HCV envelope protein in a murine model and compared antigen-specific humoral (levels of anti-E1/E2 IgG and HCV pseudoparticle neutralization) and cellular responses (numbers of antigen-specific cytokine-producing T cells) to those generated with adjuvant formulations composed of mimetics of commercial adjuvants including a squalene oil-in-water emulsion, aluminum hydroxide/monophosphoryl lipid A (MPLA) and liposome/MPLA/QS-21. In addition, we measured the longevity of these responses, tracking humoral, and cellular responses up to 6 months following vaccination. Overall, we show that the strength and longevity of anti-HCV responses can be influenced by adjuvant selection. In particular, a simple admixed sulfated S-lactosylarchaeol (SLA) archaeosome formulation generated strong levels of HCV neutralizing antibodies and polyfunctional antigen-specific CD4 T cells producing multiple cytokines such as IFN-&gamma , and IL-2. While liposome/MPLA/QS-21 as adjuvant generated superior cellular responses, the SLA E1/E2 admixed formulation was superior or equivalent to the other tested formulations in all immune parameters tested. , TNF-&alpha

unclassified unlimited available

Aussi disponible en français: À la recherche de collaborateurs industriels pour un projet sur les PIV

unlimited available public

Funded as part of the ‘Network-Enabled Platforms’ program, the Health Services Virtual Organization (HSVO) Project has developed a network-enabled platform (NEP) consisting of a messaging specification, a collection of devices, a bus interface architecture and a middleware hub (SAVOIR) that can support the authoring execution and tracking of multiple independent and integrated simulation activities. The HSVO NEP allows web devices to be coordinated, to talk to each other, to control each other, to use services from elsewhere and to use each other as services. This means that instructors and learners can have access to any services and devices at any time and location thereby supporting both scheduled and on-demand practice or instruction. Fifth International Conference on Digital Information Management, July 5-8, 2010, Lakehead University, Thunder Bay, Ontario